You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

BNT162B2.1.B.351

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

COVID-19 Trial in United States (drug, biological, other)

Active, not recruiting
  • COVID-19
  • Birmingham, Alabama
  • +21 more
Feb 2, 2023

SARS-CoV-2 Infection, COVID-19 Trial in United States (BNT162b2, BNT162b2.B.1.351)

Completed
  • SARS-CoV-2 Infection
  • COVID-19
  • BNT162b2
  • BNT162b2.B.1.351
  • Oakland, California
  • +16 more
Feb 17, 2022

COVID-19, Vaccine Reaction Trial in Paris (BNT162b2, CoV2 preS dTM adjuvanted vaccine (D614), Sanofi/GSK, CoV2 preS dTM

Active, not recruiting
  • COVID-19
  • Vaccine Reaction
  • BNT162b2
  • +2 more
  • Paris, France
    GH Broca-Cochin-Hôtel-Dieu CIC 1417 Cochin-Pasteur
Jul 7, 2022

COVID-19 Trial (Bivalent BNT162b2 (original/Omicron BA.4/BA.5) 3 microgram dose, Bivalent BNT162b2 (original/Omicron BA.4/BA.5)

Not yet recruiting
  • COVID-19
  • Bivalent BNT162b2 (original/Omicron BA.4/BA.5) 3 microgram dose
  • +3 more
  • (no location specified)
Dec 22, 2022

SARS-CoV-2 Virus, Severe Acute Respiratory Syndrome Coronavirus 2, COVID-19 Trial (Bivalent BNT162b2 (original/Omicron

Not yet recruiting
  • SARS-CoV-2 Virus
  • +2 more
  • Bivalent BNT162b2 (original/Omicron BA.4/BA.5) 3 microgram dose
  • +4 more
  • (no location specified)
Sep 14, 2022

COVID-19 Trial in Melbourne (Tozinameran, Elasomeran, Bivalent Pfizer-BioNTech)

Not yet recruiting
  • COVID-19
  • Tozinameran
  • +3 more
  • Melbourne, Victoria, Australia
    Royal Children's Hospital, Murdoch Children's Research Institute
Sep 14, 2022

Understand is COVID-19 Vaccine BNT162b2 is Safe in Indonesia

Not yet recruiting
  • COVID-19
  • BNT162b2
  • (no location specified)
Nov 16, 2022

COVID-19, SARS-CoV-2 Infection Trial in Germany (BNT162b2s01, BNT162b2)

Active, not recruiting
  • COVID-19
  • SARS-CoV-2 Infection
  • BNT162b2s01
  • BNT162b2
  • Berlin, Germany
  • +3 more
Jan 12, 2022

SARS-CoV-2 Infection, COVID-19 Trial (BNT162b5 Bivalent or BNT162b2 Bivalent 30 µg, BNT162b4 5 µg, BNT162b4 10 µg)

Not yet recruiting
  • SARS-CoV-2 Infection
  • COVID-19
  • BNT162b5 Bivalent or BNT162b2 Bivalent 30 µg
  • +3 more
  • (no location specified)
Sep 14, 2022

Response to BNT162b2 Vaccine in Adolescents With Type 1 Diabetes

Completed
  • type1diabetes
  • Blood test
  • Istanbul, Eğitim Mah. Fahrettin Kerim Gökay Caddesi, Kadıköy, Turkey
    Istanbul Medeniyet University, Professor Doctor Suleyman Yalcin
Nov 16, 2022

Serology After BBIBP-CorV Inactivated Vaccine Combined With

Completed
  • Basic BBIBP-CorV Vaccination is Not as Effective as BNT162b
  • BBIBP-CorV and/or BNT162b2 vaccine
  • Debrecen, Hajdu-Bihar, Hungary
    University of Debrecen
Sep 15, 2022

SARS-CoV2 Infection, Covid19, SARS-CoV-2 Acute Respiratory Disease Trial in Worldwide (BNT162b2, BNT162b2 (B.1.1.7 + B.1.617.2),

Active, not recruiting
  • SARS-CoV2 Infection
  • +3 more
  • BNT162b2
  • +5 more
  • Long Beach, California
  • +34 more
Jan 10, 2023

Intradermal Covid-19 Vaccine, Immungenicity and Safety, Immunocompromised Patients Trial in Hong Kong (ID BNT162b2 vaccine, IM

Recruiting
  • Intradermal Covid-19 Vaccine
  • +3 more
  • ID BNT162b2 vaccine
  • IM BNT162b2 vaccine
  • Hong Kong, Hong Kong
    Queen Mary Hospital
Feb 19, 2023

Coronavirus Infections Trial in Beer- Sheva (Pfizer BNT162b2 Vaccine)

Active, not recruiting
  • Coronavirus Infections
  • Pfizer BNT162b2 Vaccine
  • Beer- Sheva, Israel
    Soroka UMC
Aug 24, 2022

Covid19 Trial in Miami (BNT162b2 vaccine, JNJ-78436735 Vaccine)

Active, not recruiting
  • Covid19
  • BNT162b2 vaccine
  • JNJ-78436735 Vaccine
  • Miami, Florida
    University of Miami
Aug 1, 2022

Anti COVID-19 Vaccination Campaign Addressed to Employees

Completed
  • COVID-19
  • BNT162b2 COVID-19 Vaccine
  • Roma, RM, Italy
    Fondazione Policlinico Universitario "A. Gemelli" IRCCS
Mar 15, 2023

Covid-19, Protection Against COVID-19 Trial in Berlin, Mannheim (BNT162b3)

Completed
Has Results
  • Covid-19
  • Protection Against COVID-19
  • BNT162b3
  • Berlin, Germany
  • +1 more
Jun 24, 2022

Pfizer-BioNTech COVID-19 BNT162b2 Vaccine Effectiveness Study -

Recruiting
  • COVID-19
  • Primary Exposure Status of Pfizer-BioNTech COVID-19 Vaccine
  • Pasadena, California
    Kaiser Permanente Southern California
Sep 21, 2022

Myocardial Injury After BNT162b2 mRNA COVID-19 Fourth Dose

Completed
  • Myocardial Injury
  • +2 more
  • BNT162b2
  • Jerusalem, Israel
    Shaare zedek MC
May 3, 2022

SARS-CoV-2 Trial in Jiangsu (BNT162b2, Placebo)

Completed
  • SARS-CoV-2
  • BNT162b2
  • Placebo
  • Jiangsu, China
    Jiangsu Provincial Center for Disease Control and Prevention
May 9, 2022

BNT162b2 mRNA Covid-19 Vaccine Among Children in Brazil

Not yet recruiting
  • COVID-19
  • Pfizer/BioNTech BNT162b2 mRNA COVID-19 vaccine
  • CoronaVac COVID-19 vaccine
  • Toledo, Paraná, Brazil
    Unidade de Pronto Atendimento (UPA) de Toledo
May 27, 2022

Immunogenicity of BNT162b2 Covid-19 Vaccine in Elderly People

Completed
  • Immunogenicity, Vaccine
    • Thessaloníki, Thessaloniki, Greece
      G. Gennimatas General Hospital
    Aug 3, 2022

    COVID-19 Pandemic Trial in Ramat-Gan (BNT162b2 vaccine)

    Active, not recruiting
    • COVID-19 Pandemic
    • BNT162b2 vaccine
    • Ramat-Gan, Israel
      Sheba Medical Center
    Feb 8, 2022

    Healthy Participants Trial (Combination [RSVpreF+BNTb162b2], Bivalent BNT162b2 (original/Omi BA.4/BA.5), RSVpreF)

    Not yet recruiting
    • Healthy Participants
    • Combination [RSVpreF+BNTb162b2]
    • +4 more
    • (no location specified)
    May 31, 2023

    Healthy, Immunization; Infection Trial in France (3 doses of BNT162b2 vaccine, 2 dose of BNT162b2 vaccine)

    Active, not recruiting
    • Healthy
    • Immunization; Infection
    • 3 doses of BNT162b2 vaccine
    • 2 dose of BNT162b2 vaccine
    • Brest, France
    • +10 more
    Sep 2, 2022